
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current 0M4 market cap is 49.07M. The company's latest EPS is USD -0.5601 and P/E is -0.77.
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 828k | 43k | 26.58M | 36.86M | 40.5M |
Operating Income | -88.11M | -168.86M | -203.77M | -179.64M | -73.34M |
Net Income | -88.05M | -170.06M | -204.21M | -171.64M | -69.19M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 273.4M | 206.11M | 334.34M | 226.06M | 144.66M |
Total Liabilities | 45.31M | 84.37M | 242.28M | 189.16M | 154.17M |
Total Equity | 228.09M | 121.74M | 92.06M | 36.9M | -9.51M |
Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -74.7M | -139.99M | -49.36M | -168.88M | -82.34M |
Investing | 37.03M | -648k | -152.72M | 119.88M | 11.44M |
Financing | 230.41M | 63.65M | 153.02M | 94.68M | 4.09M |
Market Cap | 49.07M |
Price to Earnings Ratio | -0.77 |
Price to Sales Ratio | 1.31 |
Price to Cash Ratio | 0.49 |
Price to Book Ratio | -5.59 |
Dividend Yield | - |
Shares Outstanding | 123.53M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | - |
52 Week High | - |
52 Week Low | - |
Spread (Intraday) | 0.01 (2.92%) |
Company Name | Mersana Therapeutics Inc |
Address |
1209 orange street wilmington, delaware 19801 |
Website | https://www.mersana.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions